By Jakub Horak, Medical Cannabis Expert

Most physicians have a clear idea of what medical Cannabis should look like: a standardized capsule or oil with a precisely defined content, taken orally. The reality in patients’ living rooms, however, is far more chaotic.

A new qualitative study published in 2026 Clinical Therapeutics [1] reveals a deep gap between clinical recommendations and the real-world practices of people using Cannabis to manage the impacts of cancer.

Researchers interviewed 24 patients across eight U.S. states. The result? Instead of evidence-based treatment, what we see is closer to “creative improvisation”, driven by overwhelming product choice in dispensaries and a lack of clear guidance.

The “Candy Store Effect,” Effects Options for Consideration

For many patients, walking into a Cannabis dispensary triggers a mix of amazement and anxiety. The selection resembles a candy shop more than a healthcare setting.

Choice overload: Participants described shelves filled with everything from gummies, chocolates, and cookies to patches, lotions, and tinctures.

Trial-and-error strategy: Because of the sheer number of options, patients often buy and test products simply to see what is available that day.

Unreliable availability: A product that helped once is often unavailable the next time, forcing patients into constant changes in their “treatment routine.”

From Vaporization to Suppositories: A Mix of Routes Science Hasn’t Caught Up With

While oncologists tend to prefer oral administration, patients combine whatever methods seem useful at the moment. Three-quarters of participants alternated between multiple routes depending on their symptoms.

Many patients combine routes intuitively:

“When things get really bad, I’ll use a pipe for fast relief, but at night I prefer edibles because they last longer,” participants explained.

“A Dose the Size of a Grain of Rice”: The Dosing Nightmare

The most alarming finding is the near-total absence of precise dosing. Patients often have no idea how many milligrams of THC or CBD they are actually consuming.

Subjective estimation: Doses are measured using descriptions like “a fingertip amount” or “the size of a grain of rice.”

Home-made alchemy: Ten out of 24 patients modify products at home—boiling Cannabis in butter or mixing potent pastes with coconut oil to make them easier to use.

Distrust in labels: Patients expressed doubts about whether dispensary labels reflect reality and miss the pharmaceutical-grade certification they are used to with conventional medicines.

What Does This Mean for Practice?

This study makes one thing clear: A simple “Do you use Cannabis?” question in the clinic is not enough. Physicians need to actively explore how patients are using Cannabis and how they are dosing it.

About Jakub Horak

Jakub Horak is an international medical Cannabis specialist and independent entrepreneur with more than 15 years of experience supporting patients, clinics, cultivators, and distributors across Europe. He specializes in connecting GMP and GACP-certified cultivators with pharmacies, distributors, and regulated markets, helping optimize supply chains, pricing strategies, and market entry with a strong emphasis on quality, compliance, and long-term value.

Click the Learn More Button